Radioligand Therapy Market Recent Industry Developments and Growth Strategies Adopted by Players with Revenue Insights
The global radioligand therapy market comprises well-established and newly emerging companies. . Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the innovation in radioligand therapy from different sample types. The global radioligand therapy market was valued at $9.75 billion in 2020 and is projected to reach $16.65 billion by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 4.67% during the forecast period 2021-2031. In the comprehensive study of the global radioligand therapy market, BIS Research extensively covers the following: Market numbers on micro-segments influencing the market Market share analysis of key market players Growth share analysis of companies Impact of COVID-19 on the global radioligand therapy market Growth analysis by indication, product, biomarker, and r...